| Literature DB >> 30779021 |
Alexander Effland1, Erich Kobler2, Anne Brandenburg3, Teresa Klatzer2, Leonie Neuhäuser4, Michael Hölzel5, Jennifer Landsberg3, Thomas Pock2, Martin Rumpf4.
Abstract
PURPOSE: Cancers are almost always diagnosed by morphologic features in tissue sections. In this context, machine learning tools provide new opportunities to describe tumor immune cell interactions within the tumor microenvironment and thus provide phenotypic information that might be predictive for the response to immunotherapy.Entities:
Keywords: Digital pathology; Image reconstruction and classification; Nuclei detection; Tumor immune cell interaction; Variational networks
Mesh:
Year: 2019 PMID: 30779021 PMCID: PMC6420907 DOI: 10.1007/s11548-019-01919-z
Source DB: PubMed Journal: Int J Comput Assist Radiol Surg ISSN: 1861-6410 Impact factor: 2.924
Fig. 1Melanoma tissue sections with immunofluorescence (left) and H&E (right) staining are shown. The upper magnifying glasses depict a tumor cell (left) and a tumor nucleus (right), in the lower magnifying glasses immune cells can be observed
Cell-specific data of all scenarios
| Category | Mean color | Semi-axes (pixels) | Number/placement | |
|---|---|---|---|---|
| (1) | Tumor cell | Green |
| 25 cells, random placement |
| Tumor nucleus | Light blue |
| Only | |
| Immune cell | Red |
| 20 cells, random placement, no overlapping | |
| Immune cell nucleus | Blue |
| Only | |
| Stroma/dediff. melanoma | Blue |
| 20 cells, random placement, no overlapping | |
| (2) | Tumor cell | Light purple |
| 5 of 7 Voronoi regions filled, no overlapping |
| Tumor nucleus | Purple |
| Only | |
| Immune cell | Violet |
| 2 of 7 Voronoi regions filled, no overlapping | |
| (3) | Blood vessel | Light red | – | 1 of 11 fast marching regions filled |
| Tumor nucleus | Patches | – | 10 of 11 fast marching regions filled, no overlapping | |
| Tumor cells | Composition of patches | – | Fast marching with tumor nuclei as initial mask, three cohorts (each 55 patches) | |
| Immune cell | Composition of patches |
| Random placement, moderate overlap with tumor and immune cells allowed, three cohorts (each 60 patches) |
Fig. 2All layers that compose the noisy training images, the ground truth images and masks for Scenario 1 (first and second row), Scenario 2 (third and fourth row) and Scenario 3 (fifth and sixth row) are depicted
Fig. 3Evaluation of the loss function (left), accuracy of the segmentation (center) and the PSNR of the reconstructed PSNR image (right) for a training batch of Scenario 1
Fig. 4Training data (pairs of image and initial mask, output and ground truth) for Scenario 1 (first row) and Scenario 2 (fourth row). , and () for histological sections in Scenario 1 (second/third row) with two representative images with an immunofluorescence staining of melanoma: with blue (DAPI, cell nuclei), red (CD45, immune cell marker), green (gp100, melanocyte marker) and Scenario 2 (fifth/sixth row) H&E stains of melanoma
Fig. 5Training data (pairs of image and initial mask, output and ground truth) for Scenario 3 (first row). , and () for histological sections in Scenario 3 (second to fifth row) with H&E stains of melanoma. The input images and are magnified picture details of . All patches of the tumor nuclei used for generating the synthesized training data are extracted from
Fig. 6Pairs of annotated masks drawn by a pathologist and overlay of the annotated masks and the computed segmentation masks for the images (left) and (right) in Scenario 3
Fig. 7Pairs of images and segmentation masks computed with the U-Net model for Scenario 1 (first row), Scenario 2 (second row) and Scenario 3 (third row). The red circles indicate improperly segmented immune cells